Pharma’s (R)evolution, what’s next and what value it brings
Digital Innovation; Making Healthcare Systems Smarter
Towards the establishment of a value-based healthcare model
Enhancing national competitiveness through partnerships & investments in R&D
Paving the way for Investments in the biopharma industry in Greece; Opportunities & Challenges
EU Pharma legislation: Ηow it could impact access and innovation
Building on a holistic approach to disease prevention and management
Resilient policies through political consensus
